CSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, R

/PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) has accepted the company's...

Related Keywords

Australia , Emmanuelle Lecomte Brisset , Kim Odonohue , Jimmy Baker , Valerie Bomberger , Global Head Of Regulatory Affairs , Drug Administration , Twitter , European Medicines Agency , European Union , Biologics License Application , Authorization Application , Senior Vice President , Global Head , Regulatory Affairs , Csl ,